• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝细胞癌中杂合性缺失与p53基因突变分析

Loss of heterozygosity and analysis of mutation of p53 in hepatocellular carcinoma.

作者信息

Yumoto Y, Hanafusa T, Hada H, Morita T, Ooguchi S, Shinji N, Mitani T, Hamaya K, Koide N, Tsuji T

机构信息

Isotope Center, Okayama University, Japan.

出版信息

J Gastroenterol Hepatol. 1995 Mar-Apr;10(2):179-85. doi: 10.1111/j.1440-1746.1995.tb01075.x.

DOI:10.1111/j.1440-1746.1995.tb01075.x
PMID:7540433
Abstract

Thirty-six hepatocellular carcinoma (HCC) tissues obtained from 34 patients were classified according to histological diagnosis into six well-differentiated HCC, 20 moderately differentiated HCC and 10 poorly differentiated HCC. High molecular weight DNA was prepared from each tumour and the corresponding non-tumour tissue. Loss of heterozygosity (LOH) on chromosomes 4q, 5q, 10q, 11p, 16q, 17p, mutation of the p53 gene and polymorphism of intron 25 of the retinoblastoma (RB) gene were simultaneously analysed. The patients were composed of three cases of small HCC (the diameter of which was < 3 cm) and 31 cases of advanced HCC. Twenty-nine of 34 (85.3%) patients analysed had been exposed to hepatitis B virus and/or hepatitis C virus. The frequencies of LOH on seven chromosomes were 57.9% in 17p13.3, 45.1% in 17p, 45.1% in 11p, 41.9% in 5q, 41.9% in 16q24, 29.0% in 4q, 25.8% in 10q in advanced HCC (four of well differentiated, 18 of moderately differentiated and nine of poorly differentiated carcinoma). In contrast, LOH was observed on 4q, 5q, 16q and 17p in 33% (1/3) of the small HCC (two of well differentiated and one of moderately differentiated carcinoma). The mutation of the p53 genes and polymorphism of the RB gene were present in 25.8% (8/31) and 12.9% (4/31) of the advanced tumours, respectively, but the mutation was not found in small HCC. LOH on every chromosome and the p53 mutation were observed more frequently in more advanced tumours, and the genetic changes accumulated with the increase of the histopathological grade.(ABSTRACT TRUNCATED AT 250 WORDS)

摘要

从34例患者获取的36份肝细胞癌(HCC)组织,根据组织学诊断分为6份高分化HCC、20份中分化HCC和10份低分化HCC。从每个肿瘤组织及相应的非肿瘤组织中提取高分子量DNA。同时分析4号染色体长臂(4q)、5号染色体长臂(5q)、10号染色体长臂(10q)、11号染色体短臂(11p)、16号染色体长臂(16q)、17号染色体短臂(17p)的杂合性缺失(LOH)、p53基因的突变以及视网膜母细胞瘤(RB)基因内含子25的多态性。患者包括3例小肝癌(直径<3 cm)和31例进展期肝癌。34例接受分析的患者中有29例(85.3%)曾接触过乙型肝炎病毒和/或丙型肝炎病毒。进展期肝癌(4例高分化、18例中分化和9例低分化癌)中,7条染色体上LOH的频率分别为:17p13.3处为57.9%、17p处为45.1%、11p处为45.1%、5q处为41.9%、16q24处为41.9%、4q处为29.0%、10q处为25.8%。相比之下,小肝癌(2例高分化和1例中分化癌)中有33%(1/3)在4q、5q、16q和17p处观察到LOH。进展期肿瘤中p53基因的突变和RB基因的多态性分别占25.8%(8/31)和12.9%(4/31),但小肝癌中未发现p53基因突变。在更进展期的肿瘤中,各染色体上的LOH和p53突变更频繁地被观察到,并且遗传改变随着组织病理学分级的增加而累积。(摘要截断于250字)

相似文献

1
Loss of heterozygosity and analysis of mutation of p53 in hepatocellular carcinoma.肝细胞癌中杂合性缺失与p53基因突变分析
J Gastroenterol Hepatol. 1995 Mar-Apr;10(2):179-85. doi: 10.1111/j.1440-1746.1995.tb01075.x.
2
Genetic changes and histopathological grades in human hepatocellular carcinomas.人类肝细胞癌中的基因变化与组织病理学分级
Jpn J Cancer Res. 1993 Aug;84(8):893-9. doi: 10.1111/j.1349-7006.1993.tb02063.x.
3
Genetic alterations in hepatocellular carcinomas: association between loss of chromosome 4q and p53 gene mutations.肝细胞癌中的基因改变:4号染色体q臂缺失与p53基因突变之间的关联。
Br J Cancer. 1999 Apr;80(1-2):59-66. doi: 10.1038/sj.bjc.6690321.
4
The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.乙型肝炎病毒既往感染在日本HBs抗原阴性及抗-HCV阴性肝细胞癌患者中的作用:病因学及分子生物学研究
J Exp Clin Cancer Res. 1999 Sep;18(3):379-89.
5
Allelotype and loss of heterozygosity of p53 in primary and recurrent hepatocellular carcinomas. A study of 150 patients.原发性和复发性肝细胞癌中p53的等位基因分型及杂合性缺失:150例患者的研究
Cancer. 1994 Jan 1;73(1):42-7. doi: 10.1002/1097-0142(19940101)73:1<42::aid-cncr2820730109>3.0.co;2-d.
6
p53 gene mutation spectrum in hepatocellular carcinoma.肝细胞癌中p53基因突变谱
Cancer Res. 1992 Nov 15;52(22):6358-64.
7
Comprehensive allelotype study of hepatocellular carcinoma: potential differences in pathways to hepatocellular carcinoma between hepatitis B virus-positive and -negative tumors.肝细胞癌的全面等位基因分型研究:乙肝病毒阳性和阴性肿瘤在肝细胞癌发生途径上的潜在差异。
Hepatology. 2000 May;31(5):1073-9. doi: 10.1053/he.2000.6409.
8
Tumour suppressor p53 and Rb genes in human hepatocellular carcinoma.人类肝细胞癌中的肿瘤抑制基因p53和Rb基因
Ann Acad Med Singap. 1996 Jan;25(1):22-30.
9
Loss of constitutional heterozygosity on chromosome 5q in hepatocellular carcinoma without cirrhosis.无肝硬化肝细胞癌中5号染色体长臂的结构杂合性缺失
Br J Cancer. 1991 Dec;64(6):1083-7. doi: 10.1038/bjc.1991.468.
10
Frequent loss of heterozygosity on chromosomes 16 and 4 in human hepatocellular carcinoma.人类肝细胞癌中16号和4号染色体上杂合性的频繁缺失。
Jpn J Cancer Res. 1990 Feb;81(2):108-11. doi: 10.1111/j.1349-7006.1990.tb02534.x.

引用本文的文献

1
Transgenic zebrafish for modeling hepatocellular carcinoma.用于肝细胞癌建模的转基因斑马鱼。
MedComm (2020). 2020 Sep 3;1(2):140-156. doi: 10.1002/mco2.29. eCollection 2020 Sep.
2
New Tools for Molecular Therapy of Hepatocellular Carcinoma.肝细胞癌分子治疗的新工具
Diseases. 2015 Oct 30;3(4):325-340. doi: 10.3390/diseases3040325.
3
Expressions of HSP70 and HSP27 in hepatocellular carcinoma.热休克蛋白70和热休克蛋白27在肝细胞癌中的表达。
J Korean Med Sci. 2005 Oct;20(5):829-34. doi: 10.3346/jkms.2005.20.5.829.
4
Clinicopathological significance of loss of heterozygosity and microsatellite instability in hepatocellular carcinoma in China.中国肝细胞癌杂合性缺失与微卫星不稳定性的临床病理意义
World J Gastroenterol. 2005 May 28;11(20):3034-9. doi: 10.3748/wjg.v11.i20.3034.
5
KLF6mRNA expression in primary hepatocellular carcinoma.原发性肝细胞癌中KLF6信使核糖核酸的表达
J Huazhong Univ Sci Technolog Med Sci. 2004;24(6):585-7. doi: 10.1007/BF02911362.
6
Allelic imbalance regions on chromosomes 8p, 17p and 19p related to metastasis of hepatocellular carcinoma: comparison between matched primary and metastatic lesions in 22 patients by genome-wide microsatellite analysis.与肝细胞癌转移相关的8号染色体短臂、17号染色体短臂和19号染色体短臂上的等位基因不平衡区域:通过全基因组微卫星分析对22例患者配对的原发性和转移性病变进行比较
J Cancer Res Clin Oncol. 2003 May;129(5):279-86. doi: 10.1007/s00432-002-0407-5. Epub 2003 May 7.
7
Genetic and immunohistochemical analysis of pancreatic acinar cell carcinoma: frequent allelic loss on chromosome 11p and alterations in the APC/beta-catenin pathway.胰腺腺泡细胞癌的遗传学和免疫组化分析:11号染色体短臂频繁等位基因缺失及APC/β-连环蛋白通路改变
Am J Pathol. 2002 Mar;160(3):953-62. doi: 10.1016/s0002-9440(10)64917-6.
8
Characterization of six tumor suppressor genes and microsatellite instability in hepatocellular carcinoma in southern African blacks.南非黑人肝细胞癌中六个肿瘤抑制基因的特征及微卫星不稳定性
World J Gastroenterol. 1999 Dec;5(6):470-476. doi: 10.3748/wjg.v5.i6.470.
9
Codon 249 mutations of p53 gene in development of hepatocellular carcinoma.p53基因第249位密码子突变在肝细胞癌发生中的作用
World J Gastroenterol. 1998 Apr;4(2):125-127. doi: 10.3748/wjg.v4.i2.125.
10
Loss of heterozygosity and microsatellite instability in hepatocellular carcinoma in Taiwan.台湾地区肝细胞癌中的杂合性缺失与微卫星不稳定性
Br J Cancer. 1999 May;80(3-4):468-76. doi: 10.1038/sj.bjc.6690380.